$Table 2 from A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies$

Table 2 from A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies

<p>Safety overview.</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Dejan Juric (15126249) (author)
Další autoři:	Daniel Anderson (22644919) (author), Afshin Dowlati (15092092) (author), Jordi Rodon (15047721) (author), Iwona Lugowska (19135437) (author), Sławomir Mańdziuk (22644922) (author), Yuqin Song (15056930) (author), Feng Jung Sherida H. Woei-A-Jin (22644925) (author), Marc André (22644928) (author), Joanna Góra Tybor (22644931) (author), José-Ángel Hernández-Rivas (15050828) (author), Razelle Kurzrock (13559744) (author), Armando López-Guillermo (15028145) (author), David Schröder (22644934) (author), Rafal Stec (22644937) (author), Allison Berger (15134507) (author), Bo Chao (22644940) (author), Aleksander Chudnovsky (22644943) (author), John P. Gibbs (22644946) (author), Tao Long (22644949) (author), Dina Stroopinsky (16732851) (author), Qi Dong (22644952) (author), Anthony J. Olszanski (15031292) (author)
Vydáno:	2025
Témata:	Cancer Immuno-oncology Clinical Research and Trials Clinical Trial Results Phase II clinical trials Combination Immunotherapy Immunology Immune responses to cancer Phase I Clinical Trials
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!